Product Information

HYDROCHLOROTHIAZIDE 12.5 MG TB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0358 per EA under NDC 00172344460. Its NADAC has been published 54 times since Nov 5, 2025.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

HYDROCHLOROTHIAZIDE 12.5 MG TB

Hydrochlorothiazide
$0.0358per EA

Strength

12.5 mg/1

NDC

00172344460

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

HYDROCHLOROTHIAZIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA083177

FDA Approved

Before 1982

TE Code

AB

On Market Since

6/3/2025

Pharmacological Classes

Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has been published 54 times since Nov 5, 2025, and over the history we have for it it has declined 12.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0358 per EA
All-time high$0.0412 (Apr 15, 2026)
All-time low$0.0340 (Sep 23, 2026)
52-week high$0.0412
52-week low$0.0340
Median price$0.0404
Average price$0.0393
Largest weekly change-8.9% (Sep 23, 2026)
Weeks tracked54
Tracking sinceNov 5, 2025

Price History

1W

0.0%

1M

+5.5%

3M

-5.5%

6M

-12.2%

1Y

-12.6%

3Y

N/A

5Y

N/A

All

-12.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCHLOROTHIAZIDE 12.5 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCHLOROTHIAZIDE 12.5 MG TB, manufactured by Teva Pharmaceuticals USA Inc., is $0.0358 per EA (NDC 00172344460), effective Nov 11, 2026.

How has the price of HYDROCHLOROTHIAZIDE 12.5 MG TB changed over time?

Over the history we have for it, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has declined 12.6%. It has been tracked across 54 weekly CMS publications since Nov 5, 2025.

What are the highest and lowest recorded NADAC prices for HYDROCHLOROTHIAZIDE 12.5 MG TB?

Since Nov 5, 2025, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has ranged from a low of $0.0340 (Sep 23, 2026) to a high of $0.0412 (Apr 15, 2026), with a median of $0.0404 per EA.

Are there cheaper alternatives to HYDROCHLOROTHIAZIDE 12.5 MG TB?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROCHLOROTHIAZIDE 12.5 MG TB in a comparable dosage form, but none are currently priced below it.

Who manufactures HYDROCHLOROTHIAZIDE 12.5 MG TB?

HYDROCHLOROTHIAZIDE 12.5 MG TB (NDC 00172344460) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.